These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 11000521)

  • 21. The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck.
    Bocciardi R; Mograbi B; Pasini B; Borrello MG; Pierotti MA; Bourget I; Fischer S; Romeo G; Rossi B
    Oncogene; 1997 Nov; 15(19):2257-65. PubMed ID: 9393871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
    Uehara T; Tokumitsu Y; Nomura Y
    Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
    Conejo R; Lorenzo M
    J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart.
    Laviola L; Belsanti G; Davalli AM; Napoli R; Perrini S; Weir GC; Giorgino R; Giorgino F
    Diabetes; 2001 Dec; 50(12):2709-20. PubMed ID: 11723053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.
    Chiariello M; Visconti R; Carlomagno F; Melillo RM; Bucci C; de Franciscis V; Fox GM; Jing S; Coso OA; Gutkind JS; Fusco A; Santoro M
    Oncogene; 1998 May; 16(19):2435-45. PubMed ID: 9627110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2.
    Lorenzo MJ; Gish GD; Houghton C; Stonehouse TJ; Pawson T; Ponder BA; Smith DP
    Oncogene; 1997 Feb; 14(7):763-71. PubMed ID: 9047383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
    Pelet A; Geneste O; Edery P; Pasini A; Chappuis S; Atti T; Munnich A; Lenoir G; Lyonnet S; Billaud M
    J Clin Invest; 1998 Mar; 101(6):1415-23. PubMed ID: 9502784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve growth factor induced stimulation of Ras requires Trk interaction with Shc but does not involve phosphoinositide 3-OH kinase.
    Hallberg B; Ashcroft M; Loeb DM; Kaplan DR; Downward J
    Oncogene; 1998 Aug; 17(6):691-7. PubMed ID: 9715270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UV activation of receptor tyrosine kinase activity.
    Coffer PJ; Burgering BM; Peppelenbosch MP; Bos JL; Kruijer W
    Oncogene; 1995 Aug; 11(3):561-9. PubMed ID: 7543196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
    Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
    Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
    Zhang S; Mantel C; Broxmeyer HE
    J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphine induces desensitization of insulin receptor signaling.
    Li Y; Eitan S; Wu J; Evans CJ; Kieffer B; Sun X; Polakiewicz RD
    Mol Cell Biol; 2003 Sep; 23(17):6255-66. PubMed ID: 12917346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
    Thirone AC; Carvalho CR; Saad MJ
    Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins.
    Borrello MG; Pelicci G; Arighi E; De Filippis L; Greco A; Bongarzone I; Rizzetti M; Pelicci PG; Pierotti MA
    Oncogene; 1994 Jun; 9(6):1661-8. PubMed ID: 8183561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Gu H; Maeda H; Moon JJ; Lord JD; Yoakim M; Nelson BH; Neel BG
    Mol Cell Biol; 2000 Oct; 20(19):7109-20. PubMed ID: 10982827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors.
    Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C
    J Biol Chem; 1999 Jul; 274(29):20657-63. PubMed ID: 10400698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.
    Zeng L; Sachdev P; Yan L; Chan JL; Trenkle T; McClelland M; Welsh J; Wang LH
    Mol Cell Biol; 2000 Dec; 20(24):9212-24. PubMed ID: 11094073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.